A Study of TAS-120 in Patients With Advanced Solid Tumors

Study Name A Study of TAS-120 in Patients With Advanced Solid Tumors ClinicalTrials.gov Identifier (if applicable) NCT02052778 Clinical Trial Category (check all that apply) Beyond First Line Therapy Targeted Therapy Study Center Institution Name Massachusetts General Hospital Institution Address 55 Fruit Street City Boston State Massachusetts Zip Code 02114 List additional Institutions (include address, phone number, and website) 1. Sarah Cannon Research Institute – 93 Harley Street, London, W1G 6AD, UK 2. Institute Goustave-Roussy – 39 Rue Camille Desmoulins, Villejuif Cedex, Paris, 94805, France 3. Royal Melbourne Hospital – 305 Grattan Street, Melbourne, Victoria, 3000 Australia 4. Greenville Health System ITOR – 900 W. Faris Rd., CTC 3rd floor, Greenville, SC 29605, USA 5. Centre Léon Bérard Bât – 28 rue Laennec, Lyon 69008, France 6. INSTITUT BERGONIE – 229 COURS DE L‘ARGONNE, BORDEAUX 33076 France 7. Pitié-Salpêtrière Hospital – 47-83 Bd de l’Hopital, Paris 75013, France 8. University Hospital Ramón y Cajal – Oficina de Ensayos Clínicos...

A Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

Study Name A Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer ClinicalTrials.gov Identifier (if applicable) NCT03482102 Clinical Trial Category (check all that apply) Beyond First Line Therapy Immunotherapy Radiation Therapy Study Center Institution Name Massachusetts General Hospital Institution Address 55 Fruit Street City Boston State Massachusetts Zip Code 02114 List additional Institutions (include address, phone number, and website) This study is also being conducted at Dana Farber Cancer Institute (DFCI)/Brigham & Women’s Hospital (BWH). Study Contacts Principal Investigator Theodore S. Hong, MD P.I. Phone (617) 726-6050 P.I. Email TSHONG1@mgh.harvard.edu List additional Principal Investigators (include phone number and email) This study is also being conducted at Dana Farber Cancer Institute/Brigham & Women’s Hospital. Site Principal Investigator: Jeffrey A. Meyerhardt, MD, MPH Phone: 617-632-6855 Email: Jeffrey_Meyerhardt@dfci.harvard.edu Study Coordinator Leilana Ly Study Coordinator Phone (617) 726-8114 Study Coordinator Email LLY2@mgh.harvard.edu List additional Study...

A Phase 1 Study of CDX-1140, a Fully Human Agonist Anti-CD40 Monoclonal Antibody, in Patients With Advanced Solid Tumors

Study Name A Phase 1 Study of CDX-1140, a Fully Human Agonist Anti-CD40 Monoclonal Antibody, in Patients With Advanced Solid Tumors ClinicalTrials.gov Identifier (if applicable) NCT03329950 Clinical Trial Category (check all that apply) Beyond First Line Therapy Immunotherapy Study Center Institution Name HonorHealth Research Insititute Institution Address 10510 N. 92nd Street City Scottsdale State Arizona Zip Code 85258 Phone (480) 323-1350 List additional Institutions (include address, phone number, and website) Icahn School of Medicine at Mount Sinai (New York, NY 10029. 212-824-8449). Memorial Sloan Kettering Cancer Center (New York, NY 10065. 646-888-4384) Providence Portland Medical Center (Portland, OR 97213. 503-215-7192) Abramson Cancer Center at the University of Pennsylvania (Philadelphia, PA 19104. 215-614-7677) Study Contacts Principal Investigator Michael Gordon, MD P.I. Phone (480) 323-1350 P.I. Email michael.gordon@honorhealth.com List additional Principal Investigators (include phone number and email) Nina Bhardwaj, MD at Mount Sinai (contact Melissa Diamond at 212-824-8449 or melissa.diamond@mssm.edu) Danny Khalil,...

Avery’s Ice Cream for a Cure

Avery has a huge love for ice cream and all things chocolate. She also wants to help find a cure for cancer, specifically cholangiocarcinoma, in memory of her grandmother. So this sweet 9 year old decided to use her love of ice cream to raise money and awareness for the The Cholangiocarcinoma Foundation. Avery‘s Ice Cream for a Cure fundraiser in February generated over...

Publix Georgia Half Marathon

I successfully completed the Publix Georgia Half Marathon this morning. With the support of some great friends and family, we were able to raise $5,200 (counting $200 I understand was sent directly to the CCF) for the Cholangiocarcinoma Foundation. I am humbled and honored by all the support I’ve received, and I hope these funds help further the great work of the CCF! Thanks for your help and guidance getting the Crowdrise site set up! Fred...

Phase I study of ZW25 (bispecific antibody) in patients with advanced HER2-expressing cancers

Study Name Phase I study of ZW25 (bispecific antibody) in patients with advanced HER2-expressing cancers ClinicalTrials.gov Identifier (if applicable) NCT02892123 Clinical Trial Category (check all that apply) Beyond First Line Therapy Targeted Therapy Study Center Institution Name MD Anderson Institution Address Investigational Cancer Therapeutics City Houston State Texas Zip Code 77030 List additional Institutions (include address, phone number, and website) Sarah Cannon. Nashville, TN START, SanAntonio, TX University of Colorado, Denver, CO USC/Norris cancer center, Los Angeles, CA North West Medical Specialist, Tacoma, WA Study Contacts Principal Investigator Dr. Meric Bernstam P.I. Phone (713) 794-1226 P.I. Email fmeric@mdanderson.org List additional Principal Investigators (include phone number and email) Dr. Erika Hamilton Dr. Murali Beeram Dr. Jose Mayordomo Dr. Diana Hanna Dr. Chaves Study Coordinator Kavitha Balaji Study Coordinator Phone (713) 745-7559 Study Coordinator Email kbalaji@mdanderson.org List additional Study Coordinators (include phone number and email) START: isabel.jimenez@startsa.com; 210-593-5261 North West Medical Specialist: idhaene@nwsonline.com; 253-428-8753 OVERVIEW...

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Study Name Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations ClinicalTrials.gov Identifier (if applicable) NCT01948297 Clinical Trial Category (check all that apply) Beyond First Line Therapy Targeted Therapy Study Center Institution Name The University of Texas MD Anderson Cancer Center Institution Address 1515 Holcombe Blvd City Houston State Texas Zip Code 77030 Phone (713) 745-0746 Website http://www.mdanderson.org List additional Institutions (include address, phone number, and website) Dana-Farber Cancer Institute – Boston, Massachusetts, United States Massachusetts General Hospital – Boston, Massachusetts, United States Memorial Sloan-Kettering Hospital – New York, New York, United States Seoul National University Hospital – Seoul, Republic of Korea National Cancer Center Singapore – Singapore, Singapore Vall d’Hebron University Hospital – Barcelona, Spain Taipei Medical University Hospital – Taipei, Taiwan Study Contacts Principal Investigator Dr. Funda Meric-Bernstam P.I. Phone (713) 794-1226 P.I. Email fmeric@mdanderson.org Study Coordinator Holly Oakley Study...

A Dose Finding Study Followed by a Safety and Efficacy Study in Patients With Advanced Solid Tumors With FGF/FGFR-Related Abnormalities

Study Name A Dose Finding Study Followed by a Safety and Efficacy Study in Patients With Advanced Solid Tumors With FGF/FGFR-Related Abnormalities ClinicalTrials.gov Identifier (if applicable) NCT02052778 Clinical Trial Category (check all that apply) Beyond First Line Therapy Targeted Therapy Study Center Institution Name The University of Texas MD Anderson Cancer Center Institution Address 1515 Holcombe Blvd City Houston State Texas Zip Code 77030 Website https://www.mdanderson.org/ List additional Institutions (include address, phone number, and website) USA: Massachusetts General Hospital USA: Greenville Health System ITOR Australia: Royal Melbourne Hospital France: Institut Bergonie France: Centre Léon Bérard Bât France: Pitié-Salpêtrière Hospital France: Institute Goustave-Roussy Spain: Vall D’Hebron University Hospital Spain: University Hospital Ramón y Cajal Spain: Centro Integral Oncológico Clara Campal – Hospital Universitario Madrid Sanchinarro UK: Sarah Cannon Research Institute Study Contacts Principal Investigator Dr. Funda Meric-Bernstam P.I. Phone (713) 794-1226 P.I. Email fmeric@mdanderson.org Study Coordinator Holly Oakley Study Coordinator...

ABC-108: Study of ABC294640 (Yeliva®) in the Treatment of Patients With Advanced Cholangiocarcinoma

Study Name ABC-108: Study of ABC294640 (Yeliva®) in the Treatment of Patients With Advanced Cholangiocarcinoma ClinicalTrials.gov Identifier (if applicable) NCT03377179 Clinical Trial Category (check all that apply) Beyond First Line Therapy Study Center Institution Name MD Anderson Institution Address 1515 Holcombe Blvd City Houston State Texas Zip Code 77030 List additional Institutions (include address, phone number, and website) Mayo Clinic Hospital 5777 E. Mayo Blvd Phoenix, AZ 85054Mayo Clinic 200 First Street SW Rochester, MN 55905 Emory University Atlanta, Georgia, United States, 30322 Contact: Tyra Gaines    404-712-3308    tgaine3@emory.edu Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States, 84103 Contact: Cherie Peterson    801-587-5598    Cherie.peterson@hci.utah.edu Contact: Ignacio Garrido-Laguna, MD    801-585-0255    Ignacio.garrido-laguna@hci.utah.edu Principal Investigator: Ignacio Garrido-Laguna, MD Study Contacts Principal Investigator Dr. Shubham Pant P.I. Phone (713) 794-1776 P.I. Email MEscano@mdanderson.org List additional Principal Investigators (include phone number and email) Mayo Clinic, Arizona – Dr. Daniel Ahn Mayo Clinic, Minnesota – Dr....
Translate »

Pin It on Pinterest